Vedat Aytekin

2.4k total citations
45 papers, 219 citations indexed

About

Vedat Aytekin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vedat Aytekin has authored 45 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vedat Aytekin's work include Acute Myocardial Infarction Research (13 papers), Coronary Interventions and Diagnostics (10 papers) and Cardiac Imaging and Diagnostics (9 papers). Vedat Aytekin is often cited by papers focused on Acute Myocardial Infarction Research (13 papers), Coronary Interventions and Diagnostics (10 papers) and Cardiac Imaging and Diagnostics (9 papers). Vedat Aytekin collaborates with scholars based in Türkiye, India and United States. Vedat Aytekin's co-authors include Saide Aytekin, Özlem Yıldırımtürk, Alp Burak Çatakoğlu, Selen Yurdakul, Yelda Tayyareci, Aylin Tuğcu, B. Akpınar, İlhan Sanisoğlu, Mustafa Güden and Ertan Sağbaş and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Atherosclerosis.

In The Last Decade

Vedat Aytekin

44 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vedat Aytekin Türkiye 8 155 99 55 44 26 45 219
Pablo Pazos-López Spain 7 173 1.1× 117 1.2× 49 0.9× 50 1.1× 51 2.0× 11 261
Alessandro Mandurino‐Mirizzi Italy 10 131 0.8× 88 0.9× 42 0.8× 56 1.3× 31 1.2× 32 240
Marjatta Strandberg Finland 9 197 1.3× 136 1.4× 72 1.3× 80 1.8× 61 2.3× 24 285
Sathish Parasuraman United Kingdom 8 147 0.9× 51 0.5× 144 2.6× 35 0.8× 42 1.6× 16 285
David Kassop United States 7 223 1.4× 135 1.4× 62 1.1× 75 1.7× 33 1.3× 11 295
Naoei Isomura Japan 11 152 1.0× 123 1.2× 80 1.5× 85 1.9× 14 0.5× 31 264
Daigo Hiraya Japan 10 153 1.0× 103 1.0× 51 0.9× 90 2.0× 25 1.0× 35 307
Barış Yaylak Türkiye 11 182 1.2× 84 0.8× 53 1.0× 39 0.9× 40 1.5× 43 290
Rohit Walia India 11 206 1.3× 40 0.4× 33 0.6× 23 0.5× 38 1.5× 38 284
Joe Cuthbert United Kingdom 6 163 1.1× 89 0.9× 39 0.7× 27 0.6× 14 0.5× 14 249

Countries citing papers authored by Vedat Aytekin

Since Specialization
Citations

This map shows the geographic impact of Vedat Aytekin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vedat Aytekin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vedat Aytekin more than expected).

Fields of papers citing papers by Vedat Aytekin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vedat Aytekin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vedat Aytekin. The network helps show where Vedat Aytekin may publish in the future.

Co-authorship network of co-authors of Vedat Aytekin

This figure shows the co-authorship network connecting the top 25 collaborators of Vedat Aytekin. A scholar is included among the top collaborators of Vedat Aytekin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vedat Aytekin. Vedat Aytekin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ural, Dilek, et al.. (2024). Is There a Need for Sex‐Tailored Lipoprotein(a) Cut‐Off Values for Coronary Artery Disease Risk Stratification?. Clinical Cardiology. 47(9). e70012–e70012. 2 indexed citations
2.
Ural, Dilek, et al.. (2021). Impact of gender and diabetes on the relationship between lipoprotein (a) and coronary artery disease. Atherosclerosis. 331. e116–e116. 1 indexed citations
3.
Aytekin, Vedat. (2020). Turkish Cardiology Association Consensus Report: COVID-19 Pandemic and Cardiovascular Diseases (May 13, 2020). Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 48(Suppl 1). 1–87. 3 indexed citations
4.
Keske, Şiran, et al.. (2020). Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?. International Journal of Infectious Diseases. 102. 389–391. 2 indexed citations
5.
Aytekin, Vedat, et al.. (2019). A rare cause of acute coronary syndromes in young adults – myeloproliferative neoplasms: A case series. Revista Portuguesa de Cardiologia. 38(9). 613–617. 4 indexed citations
6.
7.
Yıldırımtürk, Özlem, et al.. (2011). Assessment of right atrial pressure using echocardiography and correlation with catheterization. Journal of Clinical Ultrasound. 39(6). 337–343. 32 indexed citations
8.
Çatakoğlu, Alp Burak & Vedat Aytekin. (2010). The Highway Technique: a new stenting technique to treat coronary bifurcation lesions. EuroIntervention. 5(7). 821–825. 1 indexed citations
9.
Erciyes, Demet, et al.. (2010). Comparison of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 10(4). 340–345. 11 indexed citations
10.
Çatakoğlu, Alp Burak, et al.. (2009). The influence of aspirin resistance on non-fatal coronary events following percutaneous coronary interventions. Archives of Medical Science. 5(4). 531–538. 7 indexed citations
11.
Çatakoğlu, Alp Burak, et al.. (2009). The interaction between endothelin-1 and C-reactive protein and their impact on long-term prognosis after percutaneous coronary interventions. Archives of Medical Science. 5(1). 38–44. 3 indexed citations
12.
Yıldırımtürk, Özlem, et al.. (2008). Açık kalp cerrahisi sonrası gelişen atriyal fibrilasyonu önlemek için kullanılan ilaçların etkinlik yönünden karşılaştırılması. Istanbul Science University (Istanbul Bilim University). 8(3). 206–212. 1 indexed citations
13.
Aytekin, Vedat, et al.. (2008). Spontaneous healing of spontaneous coronary artery dissection: a case report.. PubMed. 20(8). E237–8. 3 indexed citations
14.
Çatakoğlu, Alp Burak, et al.. (2008). The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries. Cardiovascular revascularization medicine. 9(3). 144–148. 18 indexed citations
15.
Aytekin, Vedat, et al.. (2008). Very late thrombosis of paclitaxel-eluting stent. Cardiovascular revascularization medicine. 9(4). 275–277. 4 indexed citations
16.
Çatakoğlu, Alp Burak, et al.. (2007). Impact of anemia on nonfatal coronary events after percutaneous coronary interventions. Heart and Vessels. 22(6). 383–388. 9 indexed citations
17.
Duman, Belgin Süsleyici, et al.. (2005). [The effects of phase II cardiac rehabilitation programme on patients undergone coronary bypass surgery].. PubMed. 5(2). 116–21. 3 indexed citations
18.
Duman, Belgin Süsleyici, et al.. (2005). Koroner baypas geçiren olgularda faz II kardiyak rehabilitasyon programının etkileri. 5(2). 116–121. 2 indexed citations
19.
Aytekin, Vedat, et al.. (2000). HOMOCYSTEINE IS NOT AN INDICATOR OF RESTENOSIS RISK AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY. Marmara medical journal. 13(3). 137–142. 1 indexed citations
20.
Aytekin, Vedat, et al.. (2000). Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty. International Journal of Clinical & Laboratory Research. 30(2). 93–99. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Pazos-López Breakdown of academic impact, for papers by Alessandro Mandurino‐Mirizzi Breakdown of academic impact, for papers by Marjatta Strandberg Breakdown of academic impact, for papers by Sathish Parasuraman Breakdown of academic impact, for papers by David Kassop Breakdown of academic impact, for papers by Naoei Isomura Breakdown of academic impact, for papers by Daigo Hiraya Breakdown of academic impact, for papers by Barış Yaylak Breakdown of academic impact, for papers by Rohit Walia Breakdown of academic impact, for papers by Joe Cuthbert
Rankless by CCL
2026